Bo Jan Noordman

7PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMedical parasitologyBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 27, 2026
Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial).

Sanjiv S G Gangaram Panday, Berend J van der Wilk, Ben M Eyck

|Aug 14, 2024
Prolonged Time to Surgery in Patients With Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.

Hidde C G Overtoom, Ben M Eyck, Berend J van der Wilk

|May 09, 2024
Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis.

Niels A D Guchelaar, Kazem Nasserinejad, Bianca Mostert

|Jul 12, 2023
Minimally invasive oesophagectomy as standard of care.

Bo J Noordman, Suzanne S Gisbertz

|Nov 09, 2021
Preferences for active surveillance or standard oesophagectomy: discrete-choice experiment.

Berend J van der Wilk, Inge Spronk, Bo J Noordman

|Jun 28, 2018
Patients' preferences for treatment after neoadjuvant chemoradiotherapy for oesophageal cancer.

B J Noordman, E W de Bekker-Grob, P P L O Coene

Pageof 2